238 related articles for article (PubMed ID: 32996187)
1. Efficacy of combined therapy with fish oil and phytocannabinoids in murine intestinal inflammation.
Pagano E; Iannotti FA; Piscitelli F; Romano B; Lucariello G; Venneri T; Di Marzo V; Izzo AA; Borrelli F
Phytother Res; 2021 Jan; 35(1):517-529. PubMed ID: 32996187
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease.
Borrelli F; Fasolino I; Romano B; Capasso R; Maiello F; Coppola D; Orlando P; Battista G; Pagano E; Di Marzo V; Izzo AA
Biochem Pharmacol; 2013 May; 85(9):1306-16. PubMed ID: 23415610
[TBL] [Abstract][Full Text] [Related]
3. Fish Oil, Cannabidiol and the Gut Microbiota: An Investigation in a Murine Model of Colitis.
Silvestri C; Pagano E; Lacroix S; Venneri T; Cristiano C; Calignano A; Parisi OA; Izzo AA; Di Marzo V; Borrelli F
Front Pharmacol; 2020; 11():585096. PubMed ID: 33162890
[TBL] [Abstract][Full Text] [Related]
4. An Orally Active
Pagano E; Capasso R; Piscitelli F; Romano B; Parisi OA; Finizio S; Lauritano A; Marzo VD; Izzo AA; Borrelli F
Front Pharmacol; 2016; 7():341. PubMed ID: 27757083
[TBL] [Abstract][Full Text] [Related]
5. Could the Combination of Two Non-Psychotropic Cannabinoids Counteract Neuroinflammation? Effectiveness of Cannabidiol Associated with Cannabigerol.
Mammana S; Cavalli E; Gugliandolo A; Silvestro S; Pollastro F; Bramanti P; Mazzon E
Medicina (Kaunas); 2019 Nov; 55(11):. PubMed ID: 31752240
[No Abstract] [Full Text] [Related]
6. Intestinal anti-inflammatory activity of combined quercitrin and dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, in rats with DSS-induced colitis.
Camuesco D; Comalada M; Concha A; Nieto A; Sierra S; Xaus J; Zarzuelo A; Gálvez J
Clin Nutr; 2006 Jun; 25(3):466-76. PubMed ID: 16698151
[TBL] [Abstract][Full Text] [Related]
7. In Vitro and Clinical Evaluation of Cannabigerol (CBG) Produced via Yeast Biosynthesis: A Cannabinoid with a Broad Range of Anti-Inflammatory and Skin Health-Boosting Properties.
Perez E; Fernandez JR; Fitzgerald C; Rouzard K; Tamura M; Savile C
Molecules; 2022 Jan; 27(2):. PubMed ID: 35056807
[TBL] [Abstract][Full Text] [Related]
8. Development of a Rapid LC-MS/MS Method for the Quantification of Cannabidiol, Cannabidivarin, Δ
Piscitelli F; Pagano E; Lauritano A; Izzo AA; Di Marzo V
Anal Chem; 2017 Apr; 89(8):4749-4755. PubMed ID: 28343385
[TBL] [Abstract][Full Text] [Related]
9. Topical and systemic cannabidiol improves trinitrobenzene sulfonic acid colitis in mice.
Schicho R; Storr M
Pharmacology; 2012; 89(3-4):149-55. PubMed ID: 22414698
[TBL] [Abstract][Full Text] [Related]
10. The non-euphoric phytocannabinoid cannabidivarin counteracts intestinal inflammation in mice and cytokine expression in biopsies from UC pediatric patients.
Pagano E; Romano B; Iannotti FA; Parisi OA; D'Armiento M; Pignatiello S; Coretti L; Lucafò M; Venneri T; Stocco G; Lembo F; Orlando P; Capasso R; Di Marzo V; Izzo AA; Borrelli F
Pharmacol Res; 2019 Nov; 149():104464. PubMed ID: 31553934
[TBL] [Abstract][Full Text] [Related]
11. Preventive effects of guanosine on intestinal inflammation in 2, 4-dinitrobenzene sulfonic acid (DNBS)-induced colitis in rats.
Zizzo MG; Caldara G; Bellanca A; Nuzzo D; Di Carlo M; Serio R
Inflammopharmacology; 2019 Apr; 27(2):349-359. PubMed ID: 29907915
[TBL] [Abstract][Full Text] [Related]
12. Safety assessment and redox status in rats after chronic exposure to cannabidiol and cannabigerol.
Polanska HH; Petrlakova K; Papouskova B; Hendrych M; Samadian A; Storch J; Babula P; Masarik M; Vacek J
Toxicology; 2023 Apr; 488():153460. PubMed ID: 36796712
[TBL] [Abstract][Full Text] [Related]
13. Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour.
Deiana S; Watanabe A; Yamasaki Y; Amada N; Arthur M; Fleming S; Woodcock H; Dorward P; Pigliacampo B; Close S; Platt B; Riedel G
Psychopharmacology (Berl); 2012 Feb; 219(3):859-73. PubMed ID: 21796370
[TBL] [Abstract][Full Text] [Related]
14. The Effects of Cannabinoids on Pro- and Anti-Inflammatory Cytokines: A Systematic Review of
Henshaw FR; Dewsbury LS; Lim CK; Steiner GZ
Cannabis Cannabinoid Res; 2021 Jun; 6(3):177-195. PubMed ID: 33998900
[No Abstract] [Full Text] [Related]
15. Phytocannabinoids CBD, CBG, and their Derivatives CBD-HQ and CBG-A Induced In Vitro Cytotoxicity in 2D and 3D Colon Cancer Cell Models.
Bęben D; Siwiela O; Szyjka A; Graczyk M; Rzepka D; Barg E; Moreira H
Curr Issues Mol Biol; 2024 Apr; 46(4):3626-3639. PubMed ID: 38666957
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis.
Petrosino S; Verde R; Vaia M; Allarà M; Iuvone T; Di Marzo V
J Pharmacol Exp Ther; 2018 Jun; 365(3):652-663. PubMed ID: 29632236
[TBL] [Abstract][Full Text] [Related]
17. Fish oil supplementation enhances colon recovery after experimental colitis.
Soares IP; Oliveira BAC; Baal SCS; Donatti L; Ingberman M; Beirão BCB; Appel MH; Fernandes LC
Prostaglandins Leukot Essent Fatty Acids; 2020 Dec; 163():102212. PubMed ID: 33249348
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation.
D'Argenio G; Valenti M; Scaglione G; Cosenza V; Sorrentini I; Di Marzo V
FASEB J; 2006 Mar; 20(3):568-70. PubMed ID: 16403786
[TBL] [Abstract][Full Text] [Related]
19. Differential effectiveness of selected non-psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry/seborrhoeic skin and acne treatment.
Oláh A; Markovics A; Szabó-Papp J; Szabó PT; Stott C; Zouboulis CC; Bíró T
Exp Dermatol; 2016 Sep; 25(9):701-7. PubMed ID: 27094344
[TBL] [Abstract][Full Text] [Related]
20. Single and Combined Effects of Cannabigerol (CBG) and Cannabidiol (CBD) in Mouse Models of Oxaliplatin-Associated Mechanical Sensitivity, Opioid Antinociception, and Naloxone-Precipitated Opioid Withdrawal.
Hayduk SA; Hughes AC; Winter RL; Milton MD; Ward SJ
Biomedicines; 2024 May; 12(6):. PubMed ID: 38927352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
